NRX Pharmaceuticals (NRXP) Q2 2023 Earnings

14AugConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.16
-0.15
-0.13
-0.12

Details

Expected EPS
-0.14
Actual EPS
-0.12
Surprise EPS
0.02
Surprise Percent
+14.29%

Description

NRX Pharmaceuticals (NRXP) has reported earnings of -0.12 per share for Q2 2023.

0 Comments

Share your thoughts